Lundbeckfonden Ventures

Lundbeckfonden Ventures

Lundbeckfonden Ventures is an evergreen life science venture fund established in the autumn of 2009 and wholly owned by Lundbeck Foundation

All edits

Edits on 16 April, 2020
Neelam Jhaveri
Neelam Jhaveri approved a suggestion from Golden's AI on 16 April, 2020 3:43 am
Edits made to:
Article (+22/-22 characters)

Article

Investments include Amplyx PharmaceuticalsAmplyx Pharmaceuticals, Cydan and Enterome Bioscience and exits include Spero Therapeutics, Acacia Pharma and Ziarco.

Edits on 15 April, 2020
Mevludin Mešanović"Approved suggestion #665339"
Mevludin Mešanović edited on 15 April, 2020 1:34 pm
Edits made to:
Infobox (+2/--1 properties)
Timeline (+1 events) (+7 characters)
Article (+750 characters)
People (+5 rows) (+10 cells) (+147 characters)
Companies (+9 rows) (+9 cells) (+134 characters)

Article

Lundbeckfonden Ventures is an evergreen life science venture capital firm in Copenhagen that invests in early and late stage ventures. Established in the autumn of 2009 and wholly owned by Lundbeck Foundation, it offers flexible and long-term investments. It typically invests in Series B, Series A, Series C, and in post-IPO equity. Its portfolio companies include Spero Therapeutics, SANIFIT, Reneo Pharmaceuticals, Aura Biosciences, River Vision Development, Vtesse, Ziarco, Celladon and Asante Solutions.

Since 2009, the company has invested in 31 life science companies in the US and Europe, and have an active portfolio of about 20 companies representing a wide range of therapeutic areas. It invests around DKK 350 to 400 million annually.

People

Name
Role
LinkedIn

Birgitte Schou

Vice President Finance

Casper Breum

Partner

Jette Bundgard

Associate

Johan Kördel

Senior Partner

Mette Kirstine Agger

Managing Partner

Companies

Company
CEO
Location
Products/Services

Imara

DYSIS Medical

ENTEROME Bioscience

Iconic Therapeutics

Reneo Pharmaceuticals

SANIFIT

SNIPR Biome

Tiburio Therapeutics

Trevi Therapeutics

Infobox

Company status
Active
Founded date
2009

Timeline

2009

Founded

Edits on 3 April, 2019
Golden AI
Golden AI edited on 3 April, 2019 11:50 am
Edits made to:
Infobox (+1 properties)
Edits on 25 March, 2019
Neelam Jhaveri
Neelam Jhaveri approved a suggestion from Golden's AI on 25 March, 2019 8:46 am
Edits made to:
Article (+5/-5 characters)

Article

Investments include Amplyx Pharmaceuticals, CydanCydan and Enterome Bioscience and exits include Spero Therapeutics, Acacia Pharma and Ziarco.

Edits on 11 February, 2019
Carla Faraguna
Carla Faraguna edited on 11 February, 2019 7:34 pm
Edits made to:
Infobox (+2 properties)
Article (+59/-55 characters)
Categories (+1/-1 topics)
Related Topics (+1 topics)
Topic thumbnail

Lundbeckfond Ventures Lundbeckfonden Ventures

Lundbeckfonden Ventures is an evergreen life science venture fund established in the autumn of 2009 and wholly owned by Lundbeck Foundation

Article

LundbeckfondLundbeckfonden Ventures is a venture fund generating returns to support the group's activities and operating independently from the Lundbeck Foundation controlling ownerships in H. Lundbeck A/S, ALK-Abelló and Falck.

...

The Lundbeck Foundation is a Danish foundation that was founded in 1954 by Grete Lundbeck and is worth over DKK 60 billion. They award research grants of around DKK 500 million each year to Danish-based, biomedical sciences research, primarily in the field of brain research.

...

Investments include Amplyx Pharmaceuticals, Cydan and Enterome BioscienceEnterome Bioscience and exits include Spero TherapeuticsSpero Therapeutics, Acacia Pharma and ZiarcoZiarco.

Infobox

Categories

Related Topics

Rebecca Hammond
Rebecca Hammond edited on 11 February, 2019 2:59 pm
Edits made to:
Infobox (+8 properties)
Description (+139 characters)
Article (+1083 characters)
People (+40 rows) (+81 cells) (+1390 characters)
Companies (+31 rows) (+31 cells) (+441 characters)
Categories (+1 topics)
Related Topics (+1 topics)
Topic thumbnail

Lundbeckfonden Ventures

Lundbeckfonden Ventures is an evergreen life science venture fund established in the autumn of 2009 and wholly owned by Lundbeck Foundation

Article

Lundbeckfonden Ventures is an evergreen venture fund that was founded in 2009 and is entirely owned by the Lundbeck Foundation. It invests in life science companies and focuses on projects and companies close to or in clinical development.

Lundbeckfond Ventures is a venture fund generating returns to support the group's activities and operating independently from the Lundbeck Foundation controlling ownerships in H. Lundbeck A/S, ALK-Abelló and Falck.

The Lundbeck Foundation

The Lundbeck Foundation is Danish foundation that was founded in 1954 by Grete Lundbeck and is worth over DKK 60 billion. They award research grants of around DKK 500 million each year to Danish-based, biomedical sciences research, primarily in the field of brain research.

Investments

Lundbeckfonden invests in biotechnology and medical companies worldwide with annual investments of 350 to 400 million Danish kroner.The company invests at early and late venture stage.

Investments include Amplyx Pharmaceuticals, Cydan and Enterome Bioscience and exits include Spero Therapeutics, Acacia Pharma and Ziarco.

People

Name
Role
Related Golden topics

Andreas Jurgeit

Partner

Anette Høye

Science Liaison

Anna Jo Dinesen

Student Assitant

Anne-Mare Engel

Head of Talent & Career Programmes

Bertil From

Chief Financial Officer

Britt Wilder

PA to the CEO

Casper Breum

Senior Partner

Charlotte Nørkjær

Receptionist

Christian Elling

SVP, Director of Science

Christian Elling

Managing Partner

Christoffer Kluge

Student Assistant

Dorthe Mathiasen

Accountant

Enno Hoffmann-Dose

Head of Strategy

Gitte Grove Stig

Senior Communications Advisor

Håkon Hemme Bro-Jørgensen

Investment Analyst

Hanne Harbo

Receptionist

Helene Mathiasen

Secretary

Henrik Larsen

Science Journalist

Jasper Friese

IT Manager

Jens Karkov Nørgaard

Investment Associate

Jette Brandsen Bundgaard

Associate

Johan Kördel

Senior Partner

Kim Krogsgaard

Head of Prizes, Director the The Brain Prize

Lars Torup

Programme Manager

Lene Skole

Chief Executive Officer

Page 1 of 2

Companies

Company
CEO
Location
Products/Services

Acacia Pharma

Allocure

Amplyx Pharmaceuticals

Asante Solutions

Atox Bio

Aura Biosciences

Biom'up

Bonesupport

Celladon

Cydan Development

DBV Technologies

Dysis Medical Ltd.

Enterome Bioscience

Epitherapeutics

Iconic Therapeutics

Imara

Nextim

Psioxus Therapeutics Ltd.

Reneo Pharmaceuticals

River Vision LLC.

Sanifit

Scpharmaceuticals

Spero Therapeutics

Syntaxin LTD.

Thesan

Page 1 of 2

Infobox

Categories

Related Topics

Rebecca Hammond"Initial topic creation"
Rebecca Hammond created this topic on 11 February, 2019 2:25 pm
Edits made to:
Topic thumbnail

 Lundbeckfond Ventures

Lundbeckfonden Ventures is an evergreen life science venture fund established in the autumn of 2009 and wholly owned by Lundbeck Foundation

No more activity to show.

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.